Patents by Inventor Kenneth P. LeClair

Kenneth P. LeClair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES
    Publication number: 20180371034
    Abstract: The present invention relates to methods for preparing and using multichaperone-antigen complexes. The present invention uses HOP affinity molecules in affinity methods to isolate multichaperone (multi-HSP)-antigen complexes. Such complexes have use in therapy.
    Type: Application
    Filed: January 9, 2018
    Publication date: December 27, 2018
    Applicant: Agenus Inc.
    Inventors: Kenneth P. Leclair, Andrew J. Tomlinson
  • VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION
    Publication number: 20170216428
    Abstract: The present invention relates to methods and compositions for the prevention and treatment of herpes virus infections. The invention provides antigenic peptides, and pharmaceutical compositions comprising complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also provides methods of making the antigenic peptides and complexes of antigenic peptides and adjuvants. Methods of use of the pharmaceutical compositions are also provided.
    Type: Application
    Filed: September 12, 2016
    Publication date: August 3, 2017
    Applicant: Agenus Inc.
    Inventors: Alemseged Truneh, Daniel L. Levey, Annie Xiaoyan Mo, Kenneth P. Leclair, Ramesh S. Kashi, Aston Chuanliang Liu
  • METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES
    Publication number: 20150307567
    Abstract: The present invention relates to methods for preparing and using multichaperone-antigen complexes. The present invention uses HOP affinity molecules in affinity methods to isolate multichaperone (multi-HSP)-antigen complexes. Such complexes have use in therapy.
    Type: Application
    Filed: February 6, 2015
    Publication date: October 29, 2015
    Applicant: Agenus Inc.
    Inventors: Kenneth P. Leclair, Andrew J. Tomlinson
  • VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION
    Publication number: 20140105854
    Abstract: The present invention relates to methods and compositions for the prevention and treatment of herpes virus infections. The invention provides antigenic peptides, and pharmaceutical compositions comprising complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also provides methods of making the antigenic peptides and complexes of antigenic peptides and adjuvants. Methods of use of the pharmaceutical compositions are also provided.
    Type: Application
    Filed: August 12, 2013
    Publication date: April 17, 2014
    Applicant: Agenus Inc.
    Inventors: Alemseged Truneh, Daniel L. Levey, Xiaoyan Mo, Kenneth P. Leclair, Ramesh S. Kashi, Chuanliang Liu
  • Vaccine for treatment and prevention of herpes simplex virus infection
    Patent number: 8541002
    Abstract: The present invention relates to methods and compositions for the prevention and treatment of herpes virus infections. The invention provides antigenic peptides, and pharmaceutical compositions comprising complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also provides methods of making the antigenic peptides and complexes of antigenic peptides and adjuvants. Methods of use of the pharmaceutical compositions are also provided.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: September 24, 2013
    Assignee: Agenus Inc.
    Inventors: Alemseged Truneh, Daniel L. Levey, Xiaoyan Mo, Kenneth P. Leclair, Ramesh S. Kashi, Chuanliang Liu
  • METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES
    Publication number: 20120100173
    Abstract: The present invention relates to methods for preparing and using multichaperone-antigen complexes. The present invention uses HOP affinity molecules in affinity methods to isolate multichaperone (multi-HSP)-antigen complexes. Such complexes have use in therapy.
    Type: Application
    Filed: April 2, 2010
    Publication date: April 26, 2012
    Applicant: Agenus Inc.
    Inventors: Kenneth P. Leclair, Andrew J. Tomlinson
  • Vaccine for treatment and prevention of herpes simplex virus infection
    Publication number: 20110059041
    Abstract: The present invention relates to methods and compositions for the prevention and treatment of herpes virus infections. The invention provides antigenic peptides, and pharmaceutical compositions comprising complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also provides methods of making the antigenic peptides and complexes of antigenic peptides and adjuvants. Methods of use of the pharmaceutical compositions are also provided.
    Type: Application
    Filed: September 13, 2004
    Publication date: March 10, 2011
    Inventors: Alemseged Truneh, Daniel L. Levey, Xiaoyan Mo, Kenneth P. LeClair, Ramesh S. Kashi, Liu Chuanliang